Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00216593
Status:
COMPLETED
Last Update Posted:
2011-06-21
First Post:
2005-09-13
Brief Title:
Treatment of Severe Alzheimers Disease Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study
Sponsor:
Janssen Pharmaceutica NV Belgium
Organization:
Janssen Pharmaceutica NV Belgium